SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Uwe Wollina, Psoriasis in der Hausarztpraxis, MMW - Fortschritte der Medizin, 2016, 158, S1, 40

    CrossRef

  2. 2
    Zhen-Xing Zhou, Jian-Kui Chen, Yan-Ying Hong, Ru Zhou, Dong-Mei Zhou, Li-Yun Sun, Wen-Li Qin, Tian-Cheng Wang, Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris, Journal of Clinical Laboratory Analysis, 2016, 30, 2
  3. 3
    F. C. Ernste, M. Sánchez-Menéndez, K. M. Wilton, C. S. Crowson, E. L. Matteson, H. Maradit Kremers, Cardiovascular Risk Profile at the Onset of Psoriatic Arthritis: A Population-Based Cohort Study, Arthritis Care & Research, 2015, 67, 7
  4. 4
    Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, Anshu Shrestha, Alison Sexton, Seth Seabury, Mark Lebwohl, Evaluating the economic burden of psoriasis in the United States, Journal of the American Academy of Dermatology, 2015, 72, 6, 961

    CrossRef

  5. 5
    Alexis Ogdie, Lihi Eder, Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis, International Journal of Clinical Rheumatology, 2015, 10, 6, 451

    CrossRef

  6. 6
    Lihi Eder, Arane Thavaneswaran, Vinod Chandran, Richard Cook, Dafna D Gladman, Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis, Annals of the Rheumatic Diseases, 2015, 74, 10, 1830

    CrossRef

  7. You have free access to this content7
    C. Horreau, C. Pouplard, E. Brenaut, T. Barnetche, L. Misery, B. Cribier, D. Jullien, S. Aractingi, F. Aubin, P. Joly, M. Maître, J.-P. Ortonne, C. Paul, M.-A. Richard, Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review, Journal of the European Academy of Dermatology and Venereology, 2013, 27,
  8. 8
    Elena Myasoedova, Bharath Manu Akkara Veetil, Eric L. Matteson, Hilal Maradit Kremers, Marian T. McEvoy, Cynthia S. Crowson, Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score, Scientifica, 2013, 2013, 1

    CrossRef

  9. 9
    Pedro Souteiro, Maria Augusta Vieira-Coelho, Maria Paula Serrão, Sofia Magina, Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy, Photodermatology, Photoimmunology & Photomedicine, 2013, 29, 5
  10. 10
    Hajnalka Jókai, József Szakonyi, Orsolya Kontár, Márta Marschalkó, Klára Szalai, Sarolta Kárpáti, Péter Holló, Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study, Journal of the American Academy of Dermatology, 2013, 69, 4, 523

    CrossRef

  11. 11
    Howa Yeung, Joy Wan, Abby S. Van Voorhees, Kristina Callis Duffin, Gerald G. Krueger, Robert E. Kalb, Jamie D. Weisman, Brian R. Sperber, Bruce A. Brod, Stephen M. Schleicher, Bruce F. Bebo, Daniel B. Shin, Andrea B. Troxel, Joel M. Gelfand, Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis, Journal of the American Academy of Dermatology, 2013, 68, 1, 64

    CrossRef

  12. 12
    Spyridoula Doukaki, Valentina Caputo, Maria Rita Bongiorno, Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients, Dermatology Research and Practice, 2013, 2013, 1

    CrossRef

  13. 13
    Emmilia A. Dowlatshahi, Maryam Kavousi, Tamar Nijsten, M Arfan Ikram, Albert Hofman, Oscar H. Franco, Marlies Wakkee, Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study, Journal of Investigative Dermatology, 2013, 133, 10, 2347

    CrossRef